-
If you purchased shares of Martek Biosciences Corp. (NASDAQ:MATK) prior to Dec. 21 2010 and continue to hold those MATK shares, you have certain options and you should contact the Shareholders Foundation, Inc.
-
To have your information reviewed for options and to receive notifications about this case, please use this form. You may also send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.
Investigation Overview
The U.S. Securities and Exchange Commission (SEC) announced its investigation concerning 'highly profitable and suspicious' purchases of call options for Martek Biosciences stock done in the days before Royal DSM announced it would buy all outstanding Martek shares at a 35% premium. The SEC investigation follows an investigation for investors in Martek Biosciences Corp. (NASDAQ:MATK) ...
You must register (for free) or login to view the entire investigation.
